Show results for
Refine by
Industries served
Disease Target Suppliers Serving Venezuela
63 companies found
based inSeoul, SOUTH KOREA
PROTIA Inc. aims to contribute to human health and well-being through finding new protein targets for disease prediction, early diagnosis, and development of new medicines. Based on our dedication for identification of bio-markers needed in early ...
based inAndernach, GERMANY
Since 1984 we have been focused on utilizing our expertise, experience and innovation to create market leading drug delivery solutions for our pharmaceutical partners. As a trusted technology partner for the pharmaceutical industry, we develop and ...
based inShanghai, CHINA
Ezisurg Medical Co., Ltd. (hereafter referred to as “Ezisurg Medical”) is located in Zhangjiang Hi-Tech Park, Shanghai, China. The company was founded by Henry Nie in November 2011 and specializes in the development and commercialization of high-end ...
based inMechelen, BELGIUM
Galapagos discovers, develops and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through to Phase 3 programs in inflammation, fibrosis, and other indications. Our first medicine is approved and ...
based inIrvine, CALIFORNIA (USA)
CathWorks is the leader in digital health innovations that can improve the lives of patients globally. The CathWorks FFRangio System combines advanced computational science and artificial intelligence, transforming how cardiovascular disease is ...
Wire-free and drug-free 3D FFR guidance, practical for every case. Interactive 3D reconstruction of coronary tree, color-coded by FFR value. Highly accurate FFR results for multiple vessels. Angiograms overlaid with QCA and FFR for anatomical ...
based inHowell, NEW JERSEY (USA)
Newtechbio takes bioremediation to the next level! A major game-changer backed by more than 70 years manufacturer research and development, Newtechbio provides performance-enhancing septic system treatments, lake and pond chemicals, grease ...
based inMarcy l`Etoile, FRANCE
Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. A family-owned company, bioMérieux has grown to become a world leader in the ...
based inPaoli, NEW JERSEY (USA)
Beta Lifescience is a professional biotech company committed to providing premium quality life science research reagents worldwide across research and diagnostic markets. Our strong portfolio of recombinant proteins, viral antigens, antibodies, ...
based inBagsværd, DENMARK
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. ...
Our proprietary GalXC technology leverages a naturally occurring biologic process, ribonucleic acid interference, RNAi, to create therapies that silence disease-causing genes. This platform enables Dicerna to create molecules that can ...
based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Peptides are an increasingly important class of drug. As natural ligands to many targets, they can combine agonistic or antagonistic activity with low toxicity risk and can be applied to disease ...
based inCharleston, SOUTH CAROLINA (USA)
Byo-Gon has been developing advanced biostimulants for use in tough environmental situations. Byo-Gon products enhance microbial activity to effectively solve industrial, municipal, residential and agricultural problems by Accelerating Nature. ...
based inFairfield, NEW JERSEY (USA)
Vela Diagnostics is a worldwide supplier of integrated life sciences and diagnostic solutions that help provide customers with valuable molecular information. From scientists striving to make research advances to technicians reporting the ...
based inNorth Brunswick, NEW JERSEY (USA)
Ascendia Pharmaceutical Solutions specializes in comprehensive drug development services, providing tailored formulation and manufacturing solutions from pre-formulation stages to commercialization. With a focus on overcoming pharmaceutical ...
based inLa Tronche, FRANCE
INOVOTION is a Contract Research Laboratory implementing a unique approach to in vivo evaluation for anticancer drug discovery. Our cutting-edge proprietary technology provides early analysis of your compounds before the classical preclinical stage. ...
Target validation is an essential and critical phase of the drug discovery process. This is a crucial step before starting to develop a treatment based on a targeted protein that has been identified to play a role ...
based inSanta Clara, CALIFORNIA (USA)
For more than 40 years, Agilent Technologies has been the leading provider of solutions for the detection, identification, and characterization of chemical and biological compounds. From environmental testing to semiconductor manufacturing, ...
The SureSelect Focused Exome is a highly targeted design that enables analysis of only the disease-associated targets providing deep coverage even on a benchtop sequencer. This design provides 20 or ...
based inHackney, UNITED KINGDOM
Lifebit has created a patented technology that enables researchers to run analyses on multiple, distributed datasets in-situ and avoid risky movement of highly-sensitive data. Lifebit empowers therapeutic leaders and pioneers in precision medicine ...
The velocity and volume of real world data (RWD) means it is impossible for humans alone to gain ultimate value from this type of information. Lifebit REAL uses Artificial Intelligence to make sense of RWD. Using REAL, you can unlock meaningful ...
based inNotting Hill, AUSTRALIA
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...
INOVIQ’s NETs technology is a sample preparation platform with the potential to revolutionise the performance of liquid biopsy diagnostic assays. The market potential for liquid biopsy applications is estimated at billions of dollars ...
based inRostock, GERMANY
Since 2006, CENTOGENE has helped physicians diagnose thousands of rare disease patients around the world. A quick and accurate diagnosis can end an odyssey of medical tests and visits to multiple medical specialists. It also helps physicians better ...
We work with partners to develop new disease models and new biomarkers of disease. We can also use our disease models to identify new drug targets and screen chemical compounds to ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Autoimmune disease is caused by the breaking of self-tolerance. Oncimmune’s understanding of the immune system as a mediator of disease powers the ImmunoINSIGHTS service for autoimmune ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Renasight is a test to determine if there is a genetic cause for an individual’s kidney disease or if there is an increased hereditary risk due to family history. The test uses a blood or saliva sample to test 385 genes associated with chronic ...